Neurocrine Biosciences (NBIX) Stock Chart & Stock Price History → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free NBIX Stock Alerts $142.29 +0.38 (+0.27%) (As of 05/17/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Neurocrine Biosciences Stock Price Performance5 Day Performance+2.75%1 Month Performance+7.80%3 Month Performance+7.54%6 Month Performance+30.61%Year-To-Date Performance+7.99%1 Year Performance+51.28% Receive NBIX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Neurocrine Biosciences and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… NBIX Stock Chart for Sunday, May, 19, 2024 NBIX Chart by TradingView Neurocrine Biosciences Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$141.91$142.29+0.27%$142.86$140.51641,937 shs$14.32 billion05/16/2024$142.00$141.91-0.06%$142.30$140.17663,808 shs$14.28 billion05/15/2024$138.48$142.00+2.54%$142.19$138.90684,685 shs$14.29 billion05/14/2024$136.15$138.48+1.71%$138.73$134.81637,462 shs$13.94 billion05/13/2024$136.70$136.15-0.40%$138.56$135.23712,819 shs$13.70 billion05/10/2024$139.66$136.70-2.12%$141.00$136.11679,325 shs$13.76 billion Get the Latest News and Ratings for NBIX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Neurocrine Biosciences and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$139.02$139.66+0.46%$140.60$138.95479,494 shs$14.05 billion05/08/2024$143.19$139.02-2.91%$143.54$138.15653,593 shs$13.99 billion05/07/2024$141.71$143.19+1.04%$143.86$140.90644,768 shs$14.41 billion05/06/2024$140.71$141.71+0.71%$143.57$140.55483,775 shs$14.26 billion05/03/2024$139.83$140.71+0.63%$141.69$139.25616,566 shs$14.00 billion05/02/2024$143.03$139.83-2.24%$144.09$139.64882,403 shs$13.91 billion05/01/2024$137.54$143.03+3.99%$145.22$136.011.60 million shs$14.23 billion04/30/2024$138.89$137.54-0.97%$140.47$137.34966,529 shs$13.69 billion04/29/2024$135.99$138.89+2.13%$139.37$136.05681,740 shs$13.82 billion04/26/2024$137.76$135.99-1.28%$138.61$135.17717,575 shs$13.53 billion04/25/2024$138.97$137.76-0.87%$139.37$136.06706,045 shs$13.71 billion04/24/2024$140.09$138.97-0.80%$144.70$138.01927,988 shs$13.83 billion04/23/2024$133.66$140.09+4.81%$145.00$139.221.61 million shs$13.94 billion04/22/2024$132.00$133.66+1.26%$134.18$131.79575,066 shs$13.30 billion04/19/2024$132.54$132.00-0.41%$133.65$130.13556,052 shs$13.14 billion04/18/2024$133.23$132.54-0.52%$134.20$131.00549,307 shs$13.19 billion04/17/2024$132.99$133.23+0.18%$134.44$131.36571,073 shs$13.26 billion04/16/2024$131.74$132.99+0.95%$135.17$131.491.03 million shs$13.23 billion04/15/2024$134.66$131.74-2.17%$137.00$131.52767,232 shs$13.11 billion04/12/2024$135.93$134.66-0.93%$137.78$134.63577,029 shs$13.40 billion04/11/2024$138.09$135.93-1.56%$138.67$135.28808,737 shs$13.53 billion04/10/2024$138.94$138.09-0.61%$140.54$137.99639,131 shs$13.74 billion04/09/2024$139.44$138.94-0.36%$141.38$138.00598,996 shs$13.83 billion04/08/2024$138.92$139.44+0.37%$139.68$137.72615,637 shs$13.88 billion04/05/2024$137.61$138.92+0.95%$139.75$136.03458,596 shs$13.82 billion04/04/2024$137.59$137.61+0.01%$140.43$136.741.02 million shs$13.69 billion04/03/2024$137.74$137.59-0.11%$140.19$137.36614,130 shs$13.69 billion04/02/2024$141.38$137.74-2.57%$140.61$136.12913,859 shs$13.71 billion04/01/2024$137.92$141.38+2.51%$141.73$136.85995,764 shs$14.07 billion03/29/2024$137.92$137.92$138.72$135.971.25 million shs$13.72 billion03/28/2024$137.83$137.92+0.07%$138.72$135.971.25 million shs$13.72 billion03/27/2024$141.16$137.83-2.36%$141.73$133.431.17 million shs$13.72 billion03/26/2024$140.25$141.16+0.65%$142.31$139.94594,680 shs$14.05 billion03/25/2024$141.43$140.25-0.83%$142.08$138.85498,306 shs$13.96 billionPOTUS in ‘25 Not Biden/Trump, But (Ad)And I believe when they do take the oath of office, their fingers will be crossed… and America will descend into chaos.Click here now to see my urgent election warning.03/22/2024$143.74$141.43-1.61%$145.42$137.35938,508 shs$14.07 billion03/21/2024$140.65$143.74+2.20%$148.37$139.312.51 million shs$14.30 billion03/20/2024$140.87$140.65-0.16%$141.64$137.14653,029 shs$14.00 billion03/19/2024$139.44$140.87+1.03%$141.06$138.32754,518 shs$14.02 billion03/18/2024$139.10$139.44+0.24%$141.76$138.57664,650 shs$13.88 billion03/15/2024$139.16$139.10-0.04%$142.15$138.671.73 million shs$13.84 billion03/14/2024$141.80$139.16-1.86%$142.50$137.831.17 million shs$13.85 billion03/13/2024$137.74$141.80+2.95%$141.91$138.321.07 million shs$14.11 billion03/12/2024$138.61$137.74-0.63%$139.98$137.66639,870 shs$13.71 billion03/11/2024$139.22$138.61-0.44%$140.25$137.31616,799 shs$13.79 billion03/08/2024$135.33$139.22+2.87%$140.33$136.27998,711 shs$13.85 billion03/07/2024$132.25$135.33+2.33%$135.61$132.62728,303 shs$13.47 billion03/06/2024$133.67$132.25-1.06%$134.57$131.65623,780 shs$13.16 billion03/05/2024$133.12$133.67+0.41%$135.15$132.12878,234 shs$13.30 billion03/04/2024$131.30$133.12+1.39%$134.28$131.01962,863 shs$13.25 billion03/01/2024$130.40$131.30+0.69%$132.60$129.151.32 million shs$13.07 billion02/29/2024$134.66$130.40-3.16%$136.10$130.041.72 million shs$12.98 billion02/28/2024$136.03$134.66-1.01%$136.03$133.82842,210 shs$13.40 billion02/27/2024$135.58$136.03+0.33%$136.56$134.65818,609 shs$13.54 billion02/26/2024$134.18$135.58+1.04%$136.20$133.17776,968 shs$13.49 billion02/23/2024$133.37$134.18+0.61%$134.65$132.73542,052 shs$13.35 billion02/22/2024$130.65$133.37+2.08%$133.84$130.55646,731 shs$13.27 billion02/21/2024$132.65$130.65-1.51%$133.61$129.93812,310 shs$13.00 billion02/20/2024$132.31$132.65+0.26%$134.16$131.59811,598 shs$13.20 billion02/19/2024$132.31$132.31$134.82$132.23725,700 shs$13.17 billion Related Companies: Repligen Stock Chart Exelixis Stock Chart Halozyme Therapeutics Stock Chart Denali Therapeutics Stock Chart Adaptive Biotechnologies Stock Chart Biogen Stock Chart Bio-Techne Stock Chart Qiagen Stock Chart Vaxcyte Stock Chart BioNTech Stock Chart Receive NBIX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neurocrine Biosciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NBIX) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryShocking $16T Elon Musk Crypto LeakCrypto 101 MediaHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceMost important medical advance in 100 yearsThe Oxford ClubCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMissed NVDA? Buy this AI stock NOWChaikin AnalyticsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neurocrine Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.